Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Cooper/Aspect Vision

This article was originally published in The Gray Sheet

Executive Summary

Cooper/Aspect Vision: Cooper Companies to acquire privately held contact lens maker Aspect Vision Care under a non-binding letter of intent agreement announced Sept. 3. Southampton, England-based Aspect is anticipated to generate $45-50 mil. in revenues "in its first full year with CooperVision," Cooper's specialty contact lens business, Cooper says. Aspect, which markets its lenses primarily in the United Kingdom and other European countries, "would provide CooperVision with an ideal platform to launch our specialty lens product line into the European market," stated Thomas Bender, Cooper CEO and president of CooperVision. In addition, CooperVision, which markets its lenses "predominantly in North America...would be able to offer Aspect's full range of traditional and frequent replacement products to practitioners in selected market niches in our dominant territories," Bender said. Terms were not disclosed...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008712

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel